Q-linea AB (publ) (STO:QLINEA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0380
-0.0019 (-4.76%)
Apr 25, 2025, 5:29 PM CET
-98.11%
Market Cap 177.47M
Revenue (ttm) 8.94M
Net Income (ttm) -206.13M
Shares Out 4.45B
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,903,747
Average Volume 35,570,465
Open 0.0392
Previous Close 0.0399
Day's Range 0.0380 - 0.0398
52-Week Range 0.0304 - 5.6000
Beta 1.05
RSI 35.63
Earnings Date Apr 11, 2025

About Q-linea AB

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2007
Employees 94
Stock Exchange Nasdaq Stockholm
Ticker Symbol QLINEA
Full Company Profile

Financial Performance

In 2024, Q-linea AB's revenue was 5.79 million, an increase of 4.55% compared to the previous year's 5.53 million. Losses were -216.87 million, -5.45% less than in 2023.

Financial Statements

News

There is no news available yet.